Retractable Technologies (RVP) Change in Accured Expenses (2010 - 2026)
Retractable Technologies' (RVP) quarterly Change in Accured Expenses came in at $793609.0 in Q1 2026, up 187.69% YoY from $275860.0 in Q1 2025, and up 236.68% on a QoQ basis from -$580648.0 in Q4 2025.
Retractable Technologies (RVP) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Change in Accured Expenses data on file, last reported at $793609.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 187.69% year-over-year to $793609.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $472081.0 (up 2.1% YoY) and the FY2025 annual result came in at -$45668.0, up 66.49% from the prior year.
- Change in Accured Expenses grew to $793609.0 in Q1 2026, from -$580648.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $793609.0 in Q1 2026 to a low of -$2.5 million in Q2 2022.
- A 5-year average of -$215098.6 and a median of $20556.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 7935.84% — and 2025, when it surged 599.96%.
- Tracing RVP's Change in Accured Expenses over 5 years: stood at -$1.2 million in 2022, then fell by 3.29% to -$1.2 million in 2023, then jumped by 77.14% to -$283618.0 in 2024, then slumped by 104.73% to -$580648.0 in 2025, then jumped by 236.68% to $793609.0 in 2026.
- The last three Change in Accured Expenses figures came in at $793609.0 (Q1 2026), -$580648.0 (Q4 2025), and $115236.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,609.00 |
| Mar 31, 2026 | 793,609.00 |
| Dec 31, 2025 | -580,648.00 |
| Dec 31, 2025 | -580,648.00 |
| Sep 30, 2025 | 115,236.00 |
| Sep 30, 2025 | 115,236.00 |
| Jun 30, 2025 | 143,884.00 |
| Jun 30, 2025 | 143,884.00 |
| Mar 31, 2025 | 275,860.00 |
| Mar 31, 2025 | 275,860.00 |
| Dec 31, 2024 | -283,618.00 |
| Dec 31, 2024 | -283,618.00 |
| Sep 30, 2024 | 449,554.00 |
| Sep 30, 2024 | 449,554.00 |
| Jun 30, 2024 | 20,556.00 |
| Jun 30, 2024 | 20,556.00 |
| Mar 31, 2024 | -322,754.00 |
| Mar 31, 2024 | -322,754.00 |
| Dec 31, 2023 | -1.24 Mn |
| Dec 31, 2023 | -1.24 Mn |